All lobbying filings

HOLLAND & KNIGHT LLP

Lobbying for KINDERFARMS, LLC · Manufacturer of childrens over-the-counter drug and food products

Filing 3rd Quarter - Termination

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

California

Representation ended

Sep 30, 2025

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 3

Food & Drug Administration (FDA)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
S 2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

Lobbying activity 1

Health Issues

Over-the-counter (OTC) drug and food safety and nutrition issues; OTC monograph User Fee Act (OMUFA) reauthorization; Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); FDA rulemaking on ultraprocessed food.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.